Cargando…
Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940704/ https://www.ncbi.nlm.nih.gov/pubmed/28695366 http://dx.doi.org/10.1007/s10875-017-0410-x |
_version_ | 1783321136407248896 |
---|---|
author | Ballow, Mark Wasserman, Richard L. Jolles, Stephen Chapel, Helen Berger, Mel Misbah, Siraj A. |
author_facet | Ballow, Mark Wasserman, Richard L. Jolles, Stephen Chapel, Helen Berger, Mel Misbah, Siraj A. |
author_sort | Ballow, Mark |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5940704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-59407042018-05-14 Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials Ballow, Mark Wasserman, Richard L. Jolles, Stephen Chapel, Helen Berger, Mel Misbah, Siraj A. J Clin Immunol Letter to Editor Springer US 2017-07-10 2017 /pmc/articles/PMC5940704/ /pubmed/28695366 http://dx.doi.org/10.1007/s10875-017-0410-x Text en © The Author(s) 2017, Corrected Publication May/2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made. |
spellingShingle | Letter to Editor Ballow, Mark Wasserman, Richard L. Jolles, Stephen Chapel, Helen Berger, Mel Misbah, Siraj A. Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials |
title | Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials |
title_full | Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials |
title_fullStr | Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials |
title_full_unstemmed | Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials |
title_short | Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials |
title_sort | assessment of local adverse reactions to subcutaneous immunoglobulin (scig) in clinical trials |
topic | Letter to Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940704/ https://www.ncbi.nlm.nih.gov/pubmed/28695366 http://dx.doi.org/10.1007/s10875-017-0410-x |
work_keys_str_mv | AT ballowmark assessmentoflocaladversereactionstosubcutaneousimmunoglobulinsciginclinicaltrials AT wassermanrichardl assessmentoflocaladversereactionstosubcutaneousimmunoglobulinsciginclinicaltrials AT jollesstephen assessmentoflocaladversereactionstosubcutaneousimmunoglobulinsciginclinicaltrials AT chapelhelen assessmentoflocaladversereactionstosubcutaneousimmunoglobulinsciginclinicaltrials AT bergermel assessmentoflocaladversereactionstosubcutaneousimmunoglobulinsciginclinicaltrials AT misbahsiraja assessmentoflocaladversereactionstosubcutaneousimmunoglobulinsciginclinicaltrials |